
Bryan Reynaldo Perez
Examiner (ID: 13568, Phone: (571)272-8837 , Office: P/2838 )
| Most Active Art Unit | 2838 |
| Art Unit(s) | 2838, 2839 |
| Total Applications | 860 |
| Issued Applications | 679 |
| Pending Applications | 87 |
| Abandoned Applications | 123 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7088509
[patent_doc_number] => 20050008621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Preadipocyte cell strains and uses therefore'
[patent_app_type] => utility
[patent_app_number] => 10/492034
[patent_app_country] => US
[patent_app_date] => 2002-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9920
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20050008621.pdf
[firstpage_image] =>[orig_patent_app_number] => 10492034
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/492034 | Preadipocyte cell strains and uses therefore | Oct 6, 2002 | Abandoned |
Array
(
[id] => 7210543
[patent_doc_number] => 20050053910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Gene transfer composition and method'
[patent_app_type] => utility
[patent_app_number] => 10/491580
[patent_app_country] => US
[patent_app_date] => 2002-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11578
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20050053910.pdf
[firstpage_image] =>[orig_patent_app_number] => 10491580
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/491580 | Gene transfer composition and method | Oct 1, 2002 | Abandoned |
Array
(
[id] => 7461472
[patent_doc_number] => 20040197859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods'
[patent_app_type] => new
[patent_app_number] => 10/490594
[patent_app_country] => US
[patent_app_date] => 2004-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18653
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20040197859.pdf
[firstpage_image] =>[orig_patent_app_number] => 10490594
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/490594 | Isolated DNA molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods | Sep 25, 2002 | Issued |
Array
(
[id] => 5683508
[patent_doc_number] => 20060199778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Methods and products related to non-viral transfection'
[patent_app_type] => utility
[patent_app_number] => 10/489512
[patent_app_country] => US
[patent_app_date] => 2002-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21230
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20060199778.pdf
[firstpage_image] =>[orig_patent_app_number] => 10489512
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/489512 | Methods and products related to non-viral transfection | Sep 18, 2002 | Abandoned |
Array
(
[id] => 6780180
[patent_doc_number] => 20030051262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Animal models for neurodegenerative disease'
[patent_app_type] => new
[patent_app_number] => 10/169343
[patent_app_country] => US
[patent_app_date] => 2002-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8776
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20030051262.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169343
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169343 | Animal models for neurodegenerative disease | Sep 10, 2002 | Abandoned |
Array
(
[id] => 6787657
[patent_doc_number] => 20030138896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/237496
[patent_app_country] => US
[patent_app_date] => 2002-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 45008
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20030138896.pdf
[firstpage_image] =>[orig_patent_app_number] => 10237496
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/237496 | PRO256 polypeptides | Sep 5, 2002 | Issued |
Array
(
[id] => 6746812
[patent_doc_number] => 20030023995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Inhibitor of differentiation knockout mammals and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/220911
[patent_app_country] => US
[patent_app_date] => 2002-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14968
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20030023995.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220911
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220911 | Inhibitor of differentiation knockout mammals and methods of use thereof | Sep 5, 2002 | Abandoned |
Array
(
[id] => 314524
[patent_doc_number] => 07524492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-28
[patent_title] => 'Insulin related transcription factor and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/232563
[patent_app_country] => US
[patent_app_date] => 2002-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 25
[patent_no_of_words] => 54252
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524492.pdf
[firstpage_image] =>[orig_patent_app_number] => 10232563
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/232563 | Insulin related transcription factor and uses thereof | Aug 29, 2002 | Issued |
| 10/110030 | ANIMAL MODEL FOR MESANGIAL PROLIFERATIVE NEPHRITIS | Aug 20, 2002 | Abandoned |
Array
(
[id] => 7206024
[patent_doc_number] => 20050043221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Treatment of muscular dystrophies and related disorders'
[patent_app_type] => utility
[patent_app_number] => 10/486678
[patent_app_country] => US
[patent_app_date] => 2002-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 37303
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043221.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486678
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486678 | Treatment of muscular dystrophies and related disorders | Aug 14, 2002 | Issued |
Array
(
[id] => 6717564
[patent_doc_number] => 20030028912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'ACC2-knockout mice and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/219871
[patent_app_country] => US
[patent_app_date] => 2002-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7852
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20030028912.pdf
[firstpage_image] =>[orig_patent_app_number] => 10219871
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/219871 | ACC2-knockout mice and uses thereof | Aug 14, 2002 | Abandoned |
Array
(
[id] => 6792037
[patent_doc_number] => 20030087381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Metabolically engineered organisms for enhanced production of oxaloacetate-derived biochemicals'
[patent_app_type] => new
[patent_app_number] => 10/215440
[patent_app_country] => US
[patent_app_date] => 2002-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 25236
[patent_no_of_claims] => 109
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087381.pdf
[firstpage_image] =>[orig_patent_app_number] => 10215440
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/215440 | Metabolically engineered organisms for enhanced production of oxaloacetate-derived biochemicals | Aug 8, 2002 | Abandoned |
Array
(
[id] => 326490
[patent_doc_number] => 07514261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-07
[patent_title] => 'Platelet-derived growth factor protection of cardiac myocardium'
[patent_app_type] => utility
[patent_app_number] => 10/215271
[patent_app_country] => US
[patent_app_date] => 2002-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 15134
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/514/07514261.pdf
[firstpage_image] =>[orig_patent_app_number] => 10215271
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/215271 | Platelet-derived growth factor protection of cardiac myocardium | Aug 7, 2002 | Issued |
| 10/070597 | Method of transgenic fowl construction | Aug 6, 2002 | Abandoned |
Array
(
[id] => 6974145
[patent_doc_number] => 20050039221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Phenotypic effects of ubiquinone deficiencies and methods of screening thereof'
[patent_app_type] => utility
[patent_app_number] => 10/486309
[patent_app_country] => US
[patent_app_date] => 2002-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 8653
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20050039221.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486309
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486309 | Phenotypic effects of ubiquinone deficiencies and methods of screening thereof | Aug 6, 2002 | Abandoned |
Array
(
[id] => 6689890
[patent_doc_number] => 20030033616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Imaging marker transgenes'
[patent_app_type] => new
[patent_app_number] => 10/207350
[patent_app_country] => US
[patent_app_date] => 2002-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7911
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20030033616.pdf
[firstpage_image] =>[orig_patent_app_number] => 10207350
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/207350 | Imaging marker transgenes | Jul 28, 2002 | Abandoned |
Array
(
[id] => 6720263
[patent_doc_number] => 20030053951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Use of non-invasive imaging technologies to monitor in vivo gene-expression'
[patent_app_type] => new
[patent_app_number] => 10/206893
[patent_app_country] => US
[patent_app_date] => 2002-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16668
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20030053951.pdf
[firstpage_image] =>[orig_patent_app_number] => 10206893
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/206893 | Use of non-invasive imaging technologies to monitor in vivo gene-expression | Jul 25, 2002 | Abandoned |
Array
(
[id] => 6787564
[patent_doc_number] => 20030138803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Identification and use of molecules implicated in pain'
[patent_app_type] => new
[patent_app_number] => 10/205219
[patent_app_country] => US
[patent_app_date] => 2002-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21673
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20030138803.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205219
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205219 | Identification and use of molecules implicated in pain | Jul 23, 2002 | Abandoned |
Array
(
[id] => 7395307
[patent_doc_number] => 20040031066
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2004-02-12
[patent_title] => 'Mouse model for rheumatoid arthritis'
[patent_app_type] => corrected
[patent_app_number] => 10/181167
[patent_app_country] => US
[patent_app_date] => 2002-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9294
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0031/20040031066.pdf
[firstpage_image] =>[orig_patent_app_number] => 10181167
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/181167 | Mouse model for rheumatoid arthritis | Jul 15, 2002 | Abandoned |
Array
(
[id] => 7395307
[patent_doc_number] => 20040031066
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2004-02-12
[patent_title] => 'Mouse model for rheumatoid arthritis'
[patent_app_type] => corrected
[patent_app_number] => 10/181167
[patent_app_country] => US
[patent_app_date] => 2002-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9294
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0031/20040031066.pdf
[firstpage_image] =>[orig_patent_app_number] => 10181167
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/181167 | Mouse model for rheumatoid arthritis | Jul 15, 2002 | Abandoned |